Dr. Anthony Myint, MD

Dr. Myint practices at Harbor-UCLA Medical Center in Torrance, California, part of County of Los Angeles.

Dr. Myint's NPI, 1245693225, was assigned on March 29, 2016. Dr. Myint graduated from Keck School of Medicine of USC in 2016. Dr. Myint's California license number on file is A151855.

Dr. Myint's primary practice is Harbor-UCLA Medical Center, at 1000 W Carson St, Torrance, CA 90509 in Los Angeles County. The practice phone is (310) 222-2345.

Dr. Myint's primary practice is Harbor-UCLA Medical Center in Torrance, California, part of County of Los Angeles. Dr. Myint is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Myint to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Myint practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Myint's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Myint is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Myint has a license on file in California.

CMS data shows 108 Medicare services from Dr. Myint across 5 procedure codes in 2024, for 100 Medicare patients. Medicare paid $9,239 for them.

CMS counts 100 Medicare patients who saw Dr. Myint in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 32% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Myint's median patient age at 53, with 56% women.

In 2024, Dr. Myint wrote 86 Medicare Part D claims for 49 patients. 78% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $254 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Myint for performance year 2024, reported as part of a group. Dr. Myint accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Myint as offering telehealth. CMS counts 62 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Myint, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Myint, published from 2015 to 2020. 2015 was the busiest year, with 3. The most frequent topics are Hearing Loss, Noise-Induced, Disease Models, Animal and Genetic Predisposition to Disease. Dr. Myint has published most often in PLoS Genet. Dr. Myint's most frequent co-authors are Rick Adam Friedman, MD, PhD, Ksenia Aviella Aaron, MD and Marshall Ge.

CMS Open Payments shows 34 general payments to Dr. Myint from 11 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $438.

Dr. Myint graduated from Keck School of Medicine of USC in 2016. Dr. Myint is a member of AOA.

Dr. Myint is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.